Familial Hypercholesterolaemia: New Diagnosis

Clinical Scenario

Daniel Carter, 41, presents face-to-face to discuss his NHS Health Check results. His blood tests show: total cholesterol 14.0 mmol/L, LDL 10.1 mmol/L (three times the normal upper limit). His BMI is 27, he smokes 10 cigarettes daily, and his father developed angina at 67. His grandfather died of a heart attack in his 60s. He has no symptoms. He came expecting a routine result and has no idea that his cholesterol level is severely abnormal. He has two young children.

What This Case Tests

Recognising severely elevated LDL as likely familial hypercholesterolaemia (not lifestyle-related); applying the Simon Broome or Dutch Lipid Clinic criteria; explaining FH as a genetic condition with autosomal dominant inheritance; initiating urgent high-dose statin therapy; explaining the need for cascade screening of first-degree relatives including his children.

Common Mistakes Trainees Make

The three most common mistakes are: treating this as standard hypercholesterolaemia with lifestyle advice and a low-dose statin (LDL of 10.1 is not a lifestyle problem — it is a genetic condition requiring high-intensity statin and specialist referral), not recognising FH from the cholesterol level and family history (the combination of total cholesterol above 7.5 with premature coronary disease in the family meets Simon Broome criteria), and not discussing cascade screening for the children (FH is autosomal dominant — each child has a 50% chance of inheriting it).

The Consultation Challenge

Daniel has walked in expecting a routine health check result and is about to learn he has a genetic condition that significantly increases his risk of premature heart disease. This is a breaking bad news consultation, even though it is not cancer — the impact on Daniel and his family is profound.

Start by checking what he is expecting. "Daniel, your NHS Health Check results are back. Before I go through them, what are you expecting?" He will likely say he expects everything to be normal.

Deliver the news clearly. "Your cholesterol level is significantly higher than normal — your LDL, which is the harmful type of cholesterol, is about three times the upper limit. This is not something that happens from diet or lifestyle alone. Based on your results and your family history of heart disease, I think you have a condition called familial hypercholesterolaemia — FH."

Explain what FH is. An inherited genetic condition affecting approximately 1 in 250 people. The LDL receptors in the liver do not work properly, so cholesterol accumulates in the blood from birth. It is autosomal dominant — only one copy of the gene is needed. This means each of Daniel's parents had a 50% chance of passing it on, and each of his children has a 50% chance of inheriting it.

Explain the risk honestly. Untreated FH is associated with a 50% risk of coronary heart disease by age 50 in men. Daniel is 41 and smokes — his risk is compounded. However, with treatment (high-dose statins, potentially ezetimibe, and lifestyle modification including smoking cessation), the risk can be dramatically reduced.

Initiate treatment urgently. Start atorvastatin 80mg (not 20mg — this is not standard hypercholesterolaemia). Refer to lipid clinic for specialist management and genetic testing. Address smoking cessation as an urgent priority — smoking on top of FH creates multiplicative risk.

Discuss cascade screening. "Because this is genetic, your children each have a 50% chance of having it too. The earlier we identify it, the earlier we can protect them. I would recommend cholesterol testing for both of your children and any siblings you have."

This is a lot of information for one consultation. Offer written information, a follow-up appointment, and time to process.

Time check: Deliver the results and explain FH between minutes 1-5. Explain the risk and treatment between minutes 6-8. Discuss cascade screening between minutes 9-10. Address smoking and lifestyle between minutes 11-12. Arrange follow-up in the final moments.

How Examiners Mark This Case

Data Gathering and Diagnosis: Examiners assess whether you recognise the cholesterol level as consistent with FH (total cholesterol above 7.5 with premature family CHD meets Simon Broome criteria), take a detailed family history of cardiovascular disease across generations, screen for clinical signs of FH (tendon xanthomata, corneal arcus — if face-to-face), and calculate a Dutch Lipid Clinic Network score. A trainee who treats this as standard hypercholesterolaemia will miss the diagnosis entirely.

Clinical Management and Medical Complexity: Examiners expect high-intensity statin initiation (atorvastatin 80mg, not 20mg), urgent lipid clinic referral for genetic testing and specialist management, cascade screening discussion for first-degree relatives including children, and smoking cessation as an urgent additional priority. Knowledge that FH requires lifelong treatment from the point of diagnosis demonstrates understanding of the genetic nature of the condition.

Relating to Others: Examiners assess whether you break this unexpected news sensitively (Daniel expected a routine result), explain the genetic implications clearly, discuss cascade screening for children with appropriate sensitivity (a parent learning their child may have inherited a disease), and provide hope through treatment effectiveness. Daniel should leave understanding the diagnosis, motivated to start treatment, and clear about the family implications.

Example Opening

Strong opening: "Hello Daniel, thank you for coming in to discuss your health check results. Before I go through them, what are you expecting — were you anticipating any issues?"

When delivering the diagnosis: "Daniel, your cholesterol is significantly higher than I would expect from lifestyle alone. Your LDL — the harmful cholesterol — is about three times the normal level. Combined with your father's heart disease and your grandfather's heart attack, I believe you have a condition called familial hypercholesterolaemia. It is an inherited condition — you were born with it."

When discussing the children: "Because this is genetic, there is a 50% chance that each of your children has inherited it too. I know that is a lot to hear. The good news is that if we identify it early, treatment is very effective. I would recommend we test both of them."

Avoid: "Your cholesterol is a bit high — let's try some dietary changes and recheck in 3 months." (Catastrophically underestimates a genetic condition requiring urgent treatment).

How This Appears in the SCA

FH is an important SCA topic because it tests pattern recognition (severely elevated cholesterol is not the same as lifestyle hypercholesterolaemia), genetic understanding (autosomal dominant inheritance, cascade screening), and urgent management (high-intensity statin, specialist referral). The exam assesses whether you recognise FH from the numbers and act appropriately.

Key Statistic

Familial hypercholesterolaemia affects approximately 1 in 250 people (260,000 in the UK), but over 75% are undiagnosed. Untreated FH is associated with a 50% risk of coronary heart disease by age 50 in men and 30% by age 60 in women. Early diagnosis and treatment with high-intensity statins can normalise life expectancy.

Relevant Guidelines

• NICE CG71: Familial hypercholesterolaemia — identification and management
• Simon Broome criteria for FH diagnosis
• Dutch Lipid Clinic Network criteria.

Frequently Asked Questions

How do I recognise familial hypercholesterolaemia from blood results?

Suspect FH when: total cholesterol is above 7.5 mmol/L or LDL is above 4.9 mmol/L (especially in younger patients or those without lifestyle risk factors), there is a family history of premature cardiovascular disease (men under 55, women under 60), and particularly when the cholesterol level is disproportionate to the patient's lifestyle. The Simon Broome criteria use cholesterol level plus family history to classify definite or possible FH. An LDL of 10.1 in a 41-year-old with family CHD is virtually diagnostic.

Why should I start atorvastatin 80mg rather than 20mg for FH?

FH requires high-intensity statin therapy from diagnosis because the cardiovascular risk is cumulative and has been present since birth. Standard-dose statins (20mg) used for primary prevention are insufficient for FH. NICE CG71 recommends high-intensity statin as first-line, with ezetimibe addition if the LDL target is not met. The goal is to reduce LDL by at least 50% from baseline. Starting at a low dose and titrating up wastes time in a condition where early aggressive treatment saves lives.

What is cascade screening and why is it important?

Cascade screening means testing first-degree relatives (parents, siblings, children) of a person diagnosed with FH. Because FH is autosomal dominant, each first-degree relative has a 50% chance of having the condition. Early identification allows early treatment, which normalises life expectancy. NICE recommends cascade screening for all first-degree relatives. Children can be tested from age 2 with a simple cholesterol blood test. This is one of the most cost-effective screening interventions in medicine.

How do I discuss genetic implications with a parent who has young children?

Be honest but hopeful: "Because this is inherited, each of your children has a 50-50 chance of having it too. I know that is a worrying thought. But here is the positive side — if we find it early, treatment is very effective and they can live completely normal, healthy lives. Testing them now means we can protect them from the start." Frame early testing as empowering, not frightening.

When should I refer FH to a specialist lipid clinic?

All patients with suspected or confirmed FH should be referred to a specialist lipid clinic for: genetic testing (confirmation of diagnosis and identification of the specific mutation for cascade screening), specialist lipid management (some patients require combination therapy or PCSK9 inhibitors), cardiovascular risk assessment, and coordination of cascade screening. Do not delay the referral — initiate high-dose statin in primary care while awaiting the specialist appointment.